ArticleMaterials today. Bio2026

NIR-II biomimetic nanoplatform optogenetic CD274 editing of HNSCC immunogenicity for enhanced photoimmunotherapy.

Yang Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.